(Q39557809)

English

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs

scientific article published on 24 October 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 September 2017

Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs (English)

1 reference

Europe PubMed Central

13 September 2017

anti-retroviral agent

0 references

Sub-Saharan Africa

0 references

Emmanuela Gakidou

4

object named as

Emmanuela Gakidou

1 reference

Europe PubMed Central

13 September 2017

Christopher J.L. Murray

3

object named as

Christopher J L Murray

1 reference

Europe PubMed Central

13 September 2017

Joshua A Salomon

5

object named as

Joshua A Salomon

1 reference

Europe PubMed Central

13 September 2017

author name string

Stéphane Verguet

1

1 reference

Europe PubMed Central

13 September 2017

Stephen S Lim

2

1 reference

Europe PubMed Central

13 September 2017

language of work or name

0 references

publication date

24 October 2012

1 reference

Europe PubMed Central

13 September 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

13 September 2017

207

1 reference

Europe PubMed Central

13 September 2017

1

1 reference

Europe PubMed Central

13 September 2017

72-79

1 reference

Europe PubMed Central

13 September 2017

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Overestimates of survival after HAART: implications for global scale-up efforts

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Trends in retention on antiretroviral therapy in national programs in low-income and middle-income countries

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Long-term costs and health impact of continued global fund support for antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Antiretroviral therapy and early mortality in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Sustained immunological responses to highly active antiretroviral therapy at 36 months in a Ghanaian HIV cohort

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Comparison of methods to correct survival estimates and survival regression analysis on a large HIV African cohort.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

The need for double-sampling designs in survival studies: an application to monitor PEPFAR

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Universal access: the benefits and challenges in bringing integrated HIV care to isolated and conflict affected populations in the Republic of Congo.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Challenges for scaling up ART in a resource-limited setting: a retrospective study in Kibera, Kenya

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Youth, unemployment, and male gender predict mortality in AIDS patients started on HAART in Nigeria

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Adult clinical and immunologic outcomes of the national antiretroviral treatment program in Rwanda during 2004-2005.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Mortality and loss to follow-up among HAART initiators in rural South Africa.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Two-year virologic outcomes of an alternative AIDS care model: evaluation of a peer health worker and nurse-staffed community-based program in Uganda

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Adherence to first-line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIS635

21 January 2018

Identifiers

10.1093/INFDIS/JIS635

1 reference

Europe PubMed Central

13 September 2017

1 reference

Europe PubMed Central

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39557809&oldid=1929809185"